ACSL4 and breast carcinoma: Using RNA-seq and functional proteomics, we have reported that the single overexpression of ACSL4 in breast cancer cells of low aggressiveness regulates a broad spectrum of signaling pathways involved in both tumorigenesis and resistance to conventional treatments2.